Cargando…
Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
A treat-to-target strategy, in which treatment is continuously adjusted according to the results of scheduled objective monitoring, is optimal for patients with Crohn’s disease (CD) in the era of biologics. The small bowel is a common site of intractable CD, which may result from multiple strictures...
Autor principal: | Watanabe, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609393/ https://www.ncbi.nlm.nih.gov/pubmed/33131231 http://dx.doi.org/10.5217/ir.2020.00032 |
Ejemplares similares
-
Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review
por: Le Berre, Catherine, et al.
Publicado: (2019) -
Surgical Management of Small Bowel Crohn's Disease
por: Chandrasinghe, Pramodh
Publicado: (2022) -
Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023) -
Utility of endoscopic diagnosis for postoperative small-bowel lesions in patients with Crohn’s disease at double-balloon endoscopy
por: Yamada, Koji, et al.
Publicado: (2015) -
Ultrasound of the Small Bowel in Crohn's Disease
por: Calabrese, Emma, et al.
Publicado: (2012)